Deal

Investor buys 96 percent of Mölnlycke

Investor has reached an agreement with Morgan Stanley Principal Investments and certain of its affiliated entities to acquire their 34 percent equity stake in Mölnlycke Health Care Group for a total cash consideration of EUR 510 million.

Mölnlycke is a world leading manufacturer and provider of single-use surgical and wound care products and services, primarily for the professional healthcare sector. Investor together with MSPI initially invested in Mölnlycke early 2007.

Subsequent to the transaction Investor will own 96 percent and Mölnlycke's management and board will own the remaining shares. The offer implies an enterprise value of EUR 3.2 billion.

Read more


FundInvestor Growth Capital
Portfolio CompanyMölnlycke Health Care
Date of Transaction2010-08-26
TransactionFinance round
SellerMorgan Stanley Principal Investments
Buyer
Size of TransactionEUR 510.0m
Ind. FocusLife Science
GeographySweden
StageSmall/mid-cap buyout
 

More Investor Growth Capital or Mölnlycke Health Care deals

More deals

(2011-07-13)